Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00006342
What this trial is testing

Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
Duke University 19
Testing effectiveness (Phase 2)Study completedNCT00782756
What this trial is testing

Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Brain CancerMalignant Glioma
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT01217957
What this trial is testing

Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 65
Large-scale testing (Phase 3)Ended earlyNCT02856581
What this trial is testing

Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes

Who this might be right for
Lung Carcinoma
Alliance for Clinical Trials in Oncology 23
Early research (Phase 1)WithdrawnNCT03480867
What this trial is testing

Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)

Who this might be right for
Glioblastoma Multiforme, Adult
McGill University Health Centre/Research Institute of the McGill University Health Centre
Large-scale testing (Phase 3)Study completedNCT01809691
What this trial is testing

S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 1,313
Testing effectiveness (Phase 2)Study completedNCT00033280
What this trial is testing

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 42
Testing effectiveness (Phase 2)UnknownNCT03599960
What this trial is testing

Combination Chemotherapy in Patients With Newly Diagnosed BPDCN

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Centre Hospitalier Universitaire de Besancon 26
Testing effectiveness (Phase 2)Ended earlyNCT00506779
What this trial is testing

Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma

Who this might be right for
Uterine Cancer
M.D. Anderson Cancer Center 17
Very early researchStudy completedNCT00890786
What this trial is testing

Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas

Who this might be right for
Newly Diagnosed High-Grade GliomasDiffuse Intrinsic Pontine Glioma
Children's Hospital Medical Center, Cincinnati 27
Early research (Phase 1)Study completedNCT01154439
What this trial is testing

Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 11
Early research (Phase 1)Study completedNCT00694837
What this trial is testing

Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma

Who this might be right for
Glioblastoma
Maastricht Radiation Oncology 6
Large-scale testing (Phase 3)Looking for participantsNCT04269902
What this trial is testing

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
National Cancer Institute (NCI) 247
Large-scale testing (Phase 3)Active Not RecruitingNCT03319667
What this trial is testing

Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Who this might be right for
Plasma Cell Myeloma
Sanofi 475
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Early research (Phase 1)Study completedNCT00720564
What this trial is testing

Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
City of Hope Medical Center 18
Large-scale testing (Phase 3)Active Not RecruitingNCT03871257
What this trial is testing

The Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Who this might be right for
Low Grade GliomaNeurofibromatosis Type 1Visual Pathway Glioma
National Cancer Institute (NCI) 165
Large-scale testing (Phase 3)Study completedNCT00260832
What this trial is testing

Trial of Decitabine in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Eisai Inc. 485
Not applicableStudy completedNCT04248244
What this trial is testing

Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Case Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT01912274
What this trial is testing

Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Helsinn Healthcare SA 50
Next Page